MLH1 and endometrial cancer: We further validated our observation by analysing Complex I expression in the MLH1-proficient endometrial cancer cell line KLE, transfected with either Control, non-targeting siRNA or siRNA targeting MLH1 (Fig. 2b; Supplementary Fig. 1B; p < 0.05).